 |
|
| Blog results | Results 1 - 10 of about 2,377 for taxotere for lung cancer. (0.26 seconds) |
| Sorted by relevance Sort by date |
| 23 Nov 2009 Official Title: “Open Label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetics of Docetaxel Between Two Docetaxel Products, CKD-810 and Taxotere Inj., in Patients With Advanced Solid Cancer” ... Patient is greater than 18 years of age; Advanced solid tumor; locally advanced or metastatic breast cancer which docetaxel alone therapy was adequate; locally advanced or metastatic non-small cell lung cancer which docetaxel alone therapy was adequate ... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 7 Dec 2009 by Dr West Nasser Hanna, from Indiana University and a highly respected leader in lung cancer, about maintenance therapy. He had been the expert discussant of the three key trials on maintenance therapy presented at ASCO this year (the JMEN trial ... GRACE :: Lung Cancer - http://cancergrace.org/lung/ [ More results from GRACE :: Lung Cancer ] |
| 8 Dec 2009 by Melissa Waller I just finished my 5th round of chemo (Taxotere). I am still going every week to get my weekly chemo, Erbitux. I won't have another petscan until about Jan. I am just praying that the cancer has not grown and we are at least in the same ... EmpowHer.com - Site Activity Feed - http://www.empowher.com/ [ More results from EmpowHer.com - Site Activity Feed ] |
| 8 Dec 2009 NCCN updates the NCCN Guidelines for Non-Small Cell Lung Cancer to include guidance on maintenance therapy, several new therapeutic recommendations for specific patients with Non-Small Cell Lung Cancer, and a revised staging system. ... Pemetrexed (Alimta®, Eli Lilly & Company) and erlotinib have been added as treatment options for switch maintenance with a category 2B designation and docetaxel (Taxotere®, sanofi-aventis, U.S.) has been added with a category 3 designation ... National Comprehensive Cancer Network - http://www.nccn.org/ [ More results from National Comprehensive Cancer Network ] |
| 26 Nov 2009 by Dr. NICK November 24, 2009 — Guidelines for using chemotherapy in the treatment of stage 4 nonsmall-cell lung cancer (NSCLC) have been updated by the American Society of Clinical Oncology (ASCO), and now include details of when to use targeted ... CANCER AND IMPORTANT MEDICAL NEWS - http://cancerology.blogspot.com/ [ More results from CANCER AND IMPORTANT MEDICAL NEWS ] |
| 8 Sep 2006 For locally advanced or metastatic non–small-cell lung cancer, docetaxel is indicated as monotherapy after failure of prior platinum-based chemotherapy, and for use with cisplatin in chemotherapy-naive patients. ... Medscape Ob/Gyn & Women's Health Headlines - http://www.medscape.com/womenshealth - References |
| 12 Mar 2007 by Dr West SWOG is developing a trial now that will directly compare a concurrent approach (cisplatin/etoposide/RT to 50 Gy) followed by more chemo (taxotere) to a sequential post-op approach of chemo (4 cycles of cisplatin/taxotere) followed by .... I would say that locally advanced NSCLC is the area of lung cancer where treatment needs to be individualized the most. Not only do we have a clearer sense of what “best” treatment is in the other lung cancer settings (NSCLC and SCLC) ... Onctalk - http://onctalk.com/ - References [ More results from Onctalk ] |
| 2 Dec 2009 by JR Just one in 20 cancer sufferers have surgery in an attempt to clear their cancer in some parts of the country, an audit has found. The proportion of lung cancer patients receiving treatment varies widely across the country, ... SOCIALIZED MEDICINE - http://socglory.blogspot.com/ |
| 6 Dec 2009 West's comments - gemcitabine and Taxotere is a pretty tough regimen, especially in someone who has recently undergone cisplatin and Taxol. The anemia could certainly be contributing to the fatigue. When patients are on chemotherapy... GRACE :: Forums - http://cancergrace.org/forums/index.php |
| 9 Apr 2009 Taxotere was originally approved in the U. S. for the treatment of advanced or metastatic breast cancer after failure of prior chemotherapy, as well as for patients with locally advanced or metastatic non-small-cell lung cancer. ... Johns Hopkins Health Alerts - Prostate Disorders - http://www.johnshopkinshealthalerts.com/report... [ More results from Johns Hopkins Health Alerts - Prostate Disorders ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
